Literature DB >> 26628297

Enhanced Wnt signaling by methylation-mediated loss of SFRP2 promotes osteosarcoma cell invasion.

Qiang Xiao1, Yu Yang2, Xuepu Zhang2, Qing An2.   

Abstract

Wnt signaling is essential for the initiation and progression of osteosarcoma (OS) tumors and is suppressed by the secreted frizzled-related proteins (SFRPs). The methylation-induced protein degradation reduces the activity of SFRPs and subsequently increases the activity of Wnt signaling. However, whether the methylation of SFRP2, a member of SFRPs, may be involved in the pathogenesis of OS is not known. Here, we investigated the expression levels of SFRP2 in OS specimens. We found that SFRP2 mRNA was significantly decreased and methylation of SFRP2 gene was significantly increased in malignant OS tumors as compared to the paired adjacent non-tumor tissue. Moreover, SFRP2 expression was significantly decreased in the malignant OS cell lines, SAOS2, MG63, and U2OS, but not in the primary osteoblast cells. The demethylation of SFRP2 gene by 5'-aza-deoxycytidine (5-aza-dCyd) in OS cell lines restored SFRP2 expression, at both mRNA and protein levels, and suppressed cell invasion. Furthermore, the demethylation of SFRP2 gene appeared to inhibit nuclear retention of a key Wnt signaling factor, β-catenin, in OS cell lines. Together, these data suggest that SFRP2 may function as an OS invasion suppressor by interfering with Wnt signaling, and the methylation of SFRP2 gene may promote pathogenesis of OS.

Entities:  

Keywords:  5-aza-dCyd; Cancer invasion; Methylation; Osteosarcoma (OS); Secreted frizzled-related proteins (SFRPs); Wnt signaling; β-catenin

Mesh:

Substances:

Year:  2015        PMID: 26628297     DOI: 10.1007/s13277-015-4466-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  37 in total

Review 1.  Wnt, stem cells and cancer in the intestine.

Authors:  Daniel Pinto; Hans Clevers
Journal:  Biol Cell       Date:  2005-03       Impact factor: 4.458

2.  Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.

Authors:  H Tsuchiya; K Tomita; Y Mori; N Asada; T Morinaga; S Kitano; N Yamamoto
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

3.  Regulation of chondrosarcoma invasion by MMP26.

Authors:  Xiaoshan Xu; Jinxing Ma; Chunxiao Li; Wanqiu Zhao; Yongqing Xu
Journal:  Tumour Biol       Date:  2014-09-28

Review 4.  Wnt signaling in stem and cancer stem cells.

Authors:  Jane D Holland; Alexandra Klaus; Alistair N Garratt; Walter Birchmeier
Journal:  Curr Opin Cell Biol       Date:  2013-01-21       Impact factor: 8.382

5.  Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.

Authors:  Hyunsoo Shin; Jie-Hyun Kim; Yeo Song Lee; Yong Chan Lee
Journal:  Int J Oncol       Date:  2012-01-10       Impact factor: 5.650

6.  MiR-23a functions as a tumor suppressor in osteosarcoma.

Authors:  Yu He; Chunqing Meng; Zengwu Shao; Hong Wang; Shuhua Yang
Journal:  Cell Physiol Biochem       Date:  2014-10-08

7.  SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway.

Authors:  Ming-Tzeung Chung; Hung-Cheng Lai; Huey-Kang Sytwu; Ming-De Yan; Yu-Lueng Shih; Cheng-Chang Chang; Mu-Hsien Yu; Hang-Seng Liu; Da-Wei Chu; Ya-Wen Lin
Journal:  Gynecol Oncol       Date:  2008-12-18       Impact factor: 5.482

8.  The proapoptotic effect of formononetin in human osteosarcoma cells: involvement of inactivation of ERK and Akt pathways.

Authors:  Yun Liu; JinJie He; XiaoMing Chen; Jian Li; MaoRong Shen; WenJun Yu; Yuan Yang; ZengMing Xiao
Journal:  Cell Physiol Biochem       Date:  2014-08-12

Review 9.  New molecular insights into osteosarcoma targeted therapy.

Authors:  Jilong Yang; Wei Zhang
Journal:  Curr Opin Oncol       Date:  2013-07       Impact factor: 3.645

10.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.

Authors:  Qiang Wang; Jun Cai; Jingcheng Wang; Chuanzhi Xiong; Jianning Zhao
Journal:  Tumour Biol       Date:  2014-09-17
View more
  11 in total

1.  Oncogenic role of SFRP2 in p53-mutant osteosarcoma development via autocrine and paracrine mechanism.

Authors:  Huensuk Kim; Seungyeul Yoo; Ruoji Zhou; An Xu; Jeffrey M Bernitz; Ye Yuan; Andreia M Gomes; Michael G Daniel; Jie Su; Elizabeth G Demicco; Jun Zhu; Kateri A Moore; Dung-Fang Lee; Ihor R Lemischka; Christoph Schaniel
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-01       Impact factor: 11.205

2.  An integrative analysis of DNA methylation in osteosarcoma.

Authors:  Jie Xu; Deng Li; Zhiqing Cai; Yingbin Zhang; Yulin Huang; Baohua Su; Ruofan Ma
Journal:  J Bone Oncol       Date:  2017-05-19       Impact factor: 4.072

3.  Transcriptomic analyses reveal the underlying pro-malignant functions of PTHR1 for osteosarcoma via activation of Wnt and angiogenesis pathways.

Authors:  Shenglong Li; Yujin Dong; Ke Wang; Zhe Wang; Xiaojing Zhang
Journal:  J Orthop Surg Res       Date:  2017-11-09       Impact factor: 2.359

4.  Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.

Authors:  Qiaozhen Wang; Huancai Liu; Qing Wang; Fenghua Zhou; Yongxin Liu; Yawen Zhang; Haoyu Ding; Meng Yuan; Fengjie Li; Yanchun Chen
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

5.  MicroRNA-100 suppresses human osteosarcoma cell proliferation and chemo-resistance via ZNRF2.

Authors:  Qiang Xiao; Yu Yang; Qing An; Yong Qi
Journal:  Oncotarget       Date:  2017-05-23

6.  Overexpression of FES might inhibit cell proliferation, migration, and invasion of osteosarcoma cells.

Authors:  Yang Zhao; Zhimeng Wang; Qian Wang; Liang Sun; Ming Li; Cheng Ren; Hanzhong Xue; Zhong Li; Kun Zhang; Dingjun Hao; Na Yang; Zhe Song; Teng Ma; Yao Lu
Journal:  Cancer Cell Int       Date:  2020-03-30       Impact factor: 5.722

7.  Secreted Frizzled-Related Protein 2 (sFRP2) promotes osteosarcoma invasion and metastatic potential.

Authors:  Piti Techavichit; Yang Gao; Lyazat Kurenbekova; Ryan Shuck; Lawrence A Donehower; Jason T Yustein
Journal:  BMC Cancer       Date:  2016-11-08       Impact factor: 4.430

8.  Oncopig Soft-Tissue Sarcomas Recapitulate Key Transcriptional Features of Human Sarcomas.

Authors:  Kyle M Schachtschneider; Yingkai Liu; Suvi Mäkeläinen; Ole Madsen; Laurie A Rund; Martien A M Groenen; Lawrence B Schook
Journal:  Sci Rep       Date:  2017-06-01       Impact factor: 4.379

9.  Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer.

Authors:  Hatim Boughanem; Amanda Cabrera-Mulero; Pablo Hernández-Alonso; Mercedes Clemente-Postigo; Felipe F Casanueva; Francisco José Tinahones; Sonsoles Morcillo; Ana B Crujeiras; Manuel Macias-Gonzalez
Journal:  Clin Epigenetics       Date:  2020-06-09       Impact factor: 6.551

Review 10.  Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis.

Authors:  Karlijn van Loon; Elisabeth J M Huijbers; Arjan W Griffioen
Journal:  Cancer Metastasis Rev       Date:  2020-11-02       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.